second paragraph of the report,
"In this period, Admedus made significant progress getting CardioCel® into cardiothoracic surgery centres across Europe and the US. By the end of the current period, 23 European centres and 20 centres in the US had used the product. These numbers have since risen further to 27 centres in Europe and 25 centres in the US, with over 1,000 patients implanted with CardioCel®."
increase of 9 from 43 to 52 is an increase of 20.93%
good bad or indifferent, page-27
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |